// App-Quantinova.ai

P6.243 : Evaluation of abuse potential of brivaracetam in healthy recreational CNS depressant users (P6.243)

Researchers

Presenter

  • Kerri Schoedel

Principal Investigators

  • Armel Stockis

  • Edward Sellers

Medical Centers

  • Department of Pharmacology and Toxicology, Medicine, and Psychiatry, University of Toronto, Toronto, Ontario, Canada

  • 1Altreos Research Partners Toronto ON Canada

  • DL Global Partners Inc., Toronto, Ontario, Canada,

  • UCB Pharma, Braine-l’Alleud, Belgium

Locations

  • Canada

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Alkaline phosphatase

Drug/Treatment

  • Brivaracetam

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved